Profile data is unavailable for this security.
About the company
Dottikon ES Holding AG is a Switzerland-based holding company that specializes in hazardous chemistry and focuses on the exclusive synthesis of fine chemicals for the pharmaceutical and chemical industries. Its product range includes active pharmaceutical ingredients (APIs) and pharmaceutical intermediates, as well as industrial chemicals. Its pharmaceutical products can be found in medications for, among others, heart disease, asthma, high blood pressure and ulcers. Dottikon ES Holding AG's industrial end products include food additives, cosmetics, electro-chemicals, photo-chemicals and agricultural chemicals. The Company also offers distillation plants and thin layer evaporators for the recycling of solvents, as well as high temperature incinerators for the waste treatment of hazardous waste. As of March 31, 2012, the Company had two wholly owned subsidiaries: DOTTIKON EXCLUSIVE SYNTHESIS AG and DOTTIKON ES MANAGEMENT AG. It also held a 33.9%-stake in SYSTAG, System Technik AG.
- Revenue in CHF (TTM)338.23m
- Net income in CHF86.17m
- Incorporated2005
- Employees694.00
- LocationDottikon Es Holding AG5605PO. BoxDOTTIKON 5605SwitzerlandCHE
- Phone+41 566168201
- Fax+41 566168945
- Websitehttps://dottikon.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Polypeptide Group AG | 317.86m | -50.33m | 955.48m | 1.20k | -- | 2.55 | -- | 3.01 | -1.52 | -1.52 | 9.60 | 11.31 | 0.5137 | 2.31 | 5.08 | 264,446.60 | -8.13 | 2.59 | -10.37 | 3.26 | 2.81 | 23.73 | -15.83 | 4.58 | 1.12 | -1.56 | 0.2466 | 15.79 | 14.60 | 12.36 | -762.29 | -- | 25.40 | -- |
| Cosmo Pharmaceuticals NV | 94.64m | 1.12m | 1.26bn | 325.00 | 1,034.42 | 2.77 | 82.80 | 13.36 | 0.0697 | 0.0697 | 5.87 | 26.01 | 0.1473 | 3.06 | 2.88 | 291,207.20 | 0.2051 | 0.2437 | 0.249 | 0.267 | 59.33 | 57.28 | 1.39 | 2.10 | 3.80 | 2.73 | 0.0042 | 841.86 | -5.26 | 8.07 | -93.34 | -- | 9.62 | -- |
| BB BIOTECH AG | 674.00k | -206.61m | 2.25bn | -- | -- | 0.9573 | -- | 3,333.04 | -3.76 | -3.76 | 0.0122 | 42.36 | 0.0002 | -- | -- | -- | -7.26 | 2.34 | -8.25 | 2.52 | -760.83 | 99.06 | -30,653.86 | 35.40 | -- | -0.2385 | 0.116 | 217.78 | -57.97 | -37.98 | 42.26 | -- | -- | -8.09 |
| Dottikon ES Holding AG | 338.23m | 86.17m | 3.21bn | 694.00 | 36.71 | 3.75 | 29.89 | 9.48 | 6.24 | 6.24 | 24.49 | 61.10 | 0.3135 | 0.6339 | 5.39 | 498,861.30 | 7.99 | 7.48 | 9.58 | 8.48 | 67.58 | 78.94 | 25.48 | 22.35 | 1.65 | 101.25 | 0.1062 | -- | 26.80 | 15.09 | 47.94 | 27.70 | 30.78 | -- |
| Siegfried Holding AG | 1.27bn | 112.06m | 3.93bn | 3.93k | 33.11 | 4.41 | 20.23 | 3.09 | 26.28 | 26.28 | 298.23 | 197.49 | 0.6958 | 2.27 | 3.14 | 323,288.60 | 6.17 | 6.51 | 7.67 | 7.98 | 25.20 | 23.24 | 8.86 | 9.06 | 1.39 | 7.93 | 0.3468 | 15.26 | 3.41 | 9.87 | -28.16 | 18.34 | 17.95 | 6.72 |
| BACHEM HOLDING AG | 577.32m | 111.86m | 5.99bn | 2.01k | 53.29 | 4.54 | 38.15 | 10.38 | 1.50 | 1.50 | 7.73 | 17.61 | 0.3765 | 1.23 | 3.33 | 287,794.60 | 7.29 | 8.85 | 8.17 | 10.28 | 30.65 | 31.63 | 19.38 | 19.74 | 3.04 | 29.80 | 0.0003 | 55.37 | 8.57 | 15.37 | 11.10 | 19.12 | 50.88 | 7.78 |
| Sandoz Group AG | -100.00bn | -100.00bn | 13.19bn | 23.85k | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 7.23 | -- | -90.92 | -- | -- | -- |
| Holder | Shares | % Held |
|---|---|---|
| UBS Asset Management Switzerland AGas of 31 Mar 2023 | 585.42k | 4.18% |
| VV Verm�gensverwaltung AGas of 31 Jan 2024 | 129.60k | 0.93% |
| Z�rcher Kantonalbank (Investment Management)as of 29 Feb 2024 | 94.60k | 0.68% |
| Union Bancaire Priv�e, UBP SAas of 31 Dec 2023 | 75.34k | 0.54% |
| Credit Suisse Asset Management (Schweiz) AGas of 29 Feb 2024 | 48.13k | 0.34% |
| BlackRock Fund Advisorsas of 04 Apr 2024 | 27.02k | 0.19% |
| Reichmuth & Co.as of 31 Dec 2023 | 25.00k | 0.18% |
| Pax Asset Management AGas of 29 Dec 2023 | 16.00k | 0.11% |
| Deka Investment GmbHas of 31 Dec 2023 | 12.05k | 0.09% |
| zCapital AGas of 29 Feb 2024 | 10.00k | 0.07% |
